Development of Synthetic Pan-Selectin Antagonists: A New Treatment Strategy for Chronic Inflammation in Asthma

Publisher： Karger

E-ISSN： 1423-0291|70|5|297-301

ISSN： 1015-2008

Source： Pathobiology, Vol.70, Iss.5, 2003-05, pp. : 297-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surfactant Proteins SP-A and SP-D as Modulators of the Allergic Inflammation in Asthma

By  

Pathobiology, Vol. 70, Iss. 5, 2003-05 ,pp. : 287-292

Karger

Access to resources Recommend Favorite

Long-Term NO2 Exposure Induces Pulmonary Inflammation and Progressive Development of Airflow Obstruction in C57BL/6 Mice: A Mouse Model for Chronic Obstructive Pulmonary Disease?

By  

Pathobiology, Vol. 70, Iss. 5, 2003-05 ,pp. : 284-286

Karger

Access to resources Recommend Favorite

Interleukin-12 Antagonists as New Therapeutic Agents in Inflammatory Bowel Disease

By  

Pathobiology, Vol. 70, Iss. 3, 2003-02 ,pp. : 177-183

Karger

Access to resources Recommend Favorite

Inflammation versus Immunoregulation: What Is the Key to the Development of an Effective Antiallergy Vaccine?

By  

Pathobiology, Vol. 70, Iss. 5, 2003-05 ,pp. : 270-276

Karger

Access to resources Recommend Favorite

Histological and Molecular Classification of Chronic Myeloproliferative Disorders in the Age of JAK2: Persistence of Old Questions despite New Answers

By  

Pathobiology, Vol. 74, Iss. 2, 2007-06 ,pp. : 72-80

Karger

Access to resources Recommend Favorite